Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis

Priscilla A. Williams, Kevin T. Campbell, Hessam Gharaviram, Justin L. Madrigal, Eduardo Silva

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Sphingosine-1-phosphate (S1P), a bioactive lipid, is a potent candidate for treatment of ischemic vascular disease. However, designing biomaterial systems for the controlled release of S1P to achieve therapeutic angiogenesis presents both biological and engineering challenges. Thus, the objective of this study was to design a hydrogel system that provides controlled and sustained release of S1P to establish local concentration gradients that promote neovascularization. Alginate hydrogels have been extensively studied and characterized for delivery of proangiogenic factors. We sought to explore if chitosan (0, 0.1, 0.5, or 1%) incorporation could be used as a means to control S1P release from alginate hydrogels. With increasing chitosan incorporation, hydrogels exhibited significantly denser pore structure and stiffer material properties. While 0.1 and 0.5% chitosan gels demonstrated slower respective release of S1P, release from 1% chitosan gels was similar to alginate gels alone. Furthermore, 0.5% chitosan gels induced greater sprouting and directed migration of outgrowth endothelial cells (OECs) in response to released S1P under hypoxia in vitro. Overall, this report presents a platform for a novel alginate-chitosan hydrogel of controlled composition and in situ gelation properties that can be used to control lipid release for therapeutic applications.

Original languageEnglish (US)
Pages (from-to)1003-1014
Number of pages12
JournalAnnals of Biomedical Engineering
Volume45
Issue number4
DOIs
StatePublished - Apr 1 2017

Fingerprint

Sphingosines
Alginate
Chitosan
Hydrogels
Phosphates
Gels
Lipids
Endothelial cells
Gelation
Pore structure
Biomaterials
Materials properties
Chemical analysis

Keywords

  • Composite hydrogel
  • Controlled release
  • Homing
  • Lipid
  • Outgrowth endothelial cell
  • Proangiogenic factors
  • Sphingosine-1-phosphate (S1P)

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis. / Williams, Priscilla A.; Campbell, Kevin T.; Gharaviram, Hessam; Madrigal, Justin L.; Silva, Eduardo.

In: Annals of Biomedical Engineering, Vol. 45, No. 4, 01.04.2017, p. 1003-1014.

Research output: Contribution to journalArticle

Williams, Priscilla A. ; Campbell, Kevin T. ; Gharaviram, Hessam ; Madrigal, Justin L. ; Silva, Eduardo. / Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis. In: Annals of Biomedical Engineering. 2017 ; Vol. 45, No. 4. pp. 1003-1014.
@article{656db737d6364594b20b3794f75a8ec0,
title = "Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis",
abstract = "Sphingosine-1-phosphate (S1P), a bioactive lipid, is a potent candidate for treatment of ischemic vascular disease. However, designing biomaterial systems for the controlled release of S1P to achieve therapeutic angiogenesis presents both biological and engineering challenges. Thus, the objective of this study was to design a hydrogel system that provides controlled and sustained release of S1P to establish local concentration gradients that promote neovascularization. Alginate hydrogels have been extensively studied and characterized for delivery of proangiogenic factors. We sought to explore if chitosan (0, 0.1, 0.5, or 1{\%}) incorporation could be used as a means to control S1P release from alginate hydrogels. With increasing chitosan incorporation, hydrogels exhibited significantly denser pore structure and stiffer material properties. While 0.1 and 0.5{\%} chitosan gels demonstrated slower respective release of S1P, release from 1{\%} chitosan gels was similar to alginate gels alone. Furthermore, 0.5{\%} chitosan gels induced greater sprouting and directed migration of outgrowth endothelial cells (OECs) in response to released S1P under hypoxia in vitro. Overall, this report presents a platform for a novel alginate-chitosan hydrogel of controlled composition and in situ gelation properties that can be used to control lipid release for therapeutic applications.",
keywords = "Composite hydrogel, Controlled release, Homing, Lipid, Outgrowth endothelial cell, Proangiogenic factors, Sphingosine-1-phosphate (S1P)",
author = "Williams, {Priscilla A.} and Campbell, {Kevin T.} and Hessam Gharaviram and Madrigal, {Justin L.} and Eduardo Silva",
year = "2017",
month = "4",
day = "1",
doi = "10.1007/s10439-016-1768-2",
language = "English (US)",
volume = "45",
pages = "1003--1014",
journal = "Annals of Biomedical Engineering",
issn = "0090-6964",
publisher = "Springer Netherlands",
number = "4",

}

TY - JOUR

T1 - Alginate-Chitosan Hydrogels Provide a Sustained Gradient of Sphingosine-1-Phosphate for Therapeutic Angiogenesis

AU - Williams, Priscilla A.

AU - Campbell, Kevin T.

AU - Gharaviram, Hessam

AU - Madrigal, Justin L.

AU - Silva, Eduardo

PY - 2017/4/1

Y1 - 2017/4/1

N2 - Sphingosine-1-phosphate (S1P), a bioactive lipid, is a potent candidate for treatment of ischemic vascular disease. However, designing biomaterial systems for the controlled release of S1P to achieve therapeutic angiogenesis presents both biological and engineering challenges. Thus, the objective of this study was to design a hydrogel system that provides controlled and sustained release of S1P to establish local concentration gradients that promote neovascularization. Alginate hydrogels have been extensively studied and characterized for delivery of proangiogenic factors. We sought to explore if chitosan (0, 0.1, 0.5, or 1%) incorporation could be used as a means to control S1P release from alginate hydrogels. With increasing chitosan incorporation, hydrogels exhibited significantly denser pore structure and stiffer material properties. While 0.1 and 0.5% chitosan gels demonstrated slower respective release of S1P, release from 1% chitosan gels was similar to alginate gels alone. Furthermore, 0.5% chitosan gels induced greater sprouting and directed migration of outgrowth endothelial cells (OECs) in response to released S1P under hypoxia in vitro. Overall, this report presents a platform for a novel alginate-chitosan hydrogel of controlled composition and in situ gelation properties that can be used to control lipid release for therapeutic applications.

AB - Sphingosine-1-phosphate (S1P), a bioactive lipid, is a potent candidate for treatment of ischemic vascular disease. However, designing biomaterial systems for the controlled release of S1P to achieve therapeutic angiogenesis presents both biological and engineering challenges. Thus, the objective of this study was to design a hydrogel system that provides controlled and sustained release of S1P to establish local concentration gradients that promote neovascularization. Alginate hydrogels have been extensively studied and characterized for delivery of proangiogenic factors. We sought to explore if chitosan (0, 0.1, 0.5, or 1%) incorporation could be used as a means to control S1P release from alginate hydrogels. With increasing chitosan incorporation, hydrogels exhibited significantly denser pore structure and stiffer material properties. While 0.1 and 0.5% chitosan gels demonstrated slower respective release of S1P, release from 1% chitosan gels was similar to alginate gels alone. Furthermore, 0.5% chitosan gels induced greater sprouting and directed migration of outgrowth endothelial cells (OECs) in response to released S1P under hypoxia in vitro. Overall, this report presents a platform for a novel alginate-chitosan hydrogel of controlled composition and in situ gelation properties that can be used to control lipid release for therapeutic applications.

KW - Composite hydrogel

KW - Controlled release

KW - Homing

KW - Lipid

KW - Outgrowth endothelial cell

KW - Proangiogenic factors

KW - Sphingosine-1-phosphate (S1P)

UR - http://www.scopus.com/inward/record.url?scp=85000605923&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85000605923&partnerID=8YFLogxK

U2 - 10.1007/s10439-016-1768-2

DO - 10.1007/s10439-016-1768-2

M3 - Article

C2 - 27904998

AN - SCOPUS:85000605923

VL - 45

SP - 1003

EP - 1014

JO - Annals of Biomedical Engineering

JF - Annals of Biomedical Engineering

SN - 0090-6964

IS - 4

ER -